FDA Advisory Panel To Review Dental Amalgam

Main Category: Dentistry
Also Included In: Regulatory Affairs / Drug Approvals
Article Date: 11 Jun 2010 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  


Current Article Ratings:

Patient / Public:5 stars

5 (2 votes)

Healthcare Prof:not yet rated


The U.S. Food and Drug Administration announced plans to hold an advisory panel on Dec. 14-15, 2010, to discuss several scientific issues that may affect the regulation of dental amalgam, used for direct filling of carious lesions or structural defects in teeth. The panel meeting will focus particularly on the potential risk to vulnerable populations, such as pregnant women, fetuses, and young children.

Used to treat tooth decay, dental amalgam is a mixture of metals, composed of liquid mercury and a powdered amalgam alloy, composed primarily of silver, tin, and copper.

On July 28, 2009, the FDA issued a final rule that reclassified dental mercury from a class I device to class II, classified dental amalgam as a class II device, and designated special controls for dental amalgam, mercury and amalgam alloy. The special control for the devices is a guidance titled, "Class II Special Controls Guidance Document: Dental Amalgam, Mercury and Amalgam Alloy."

Since that time, the agency has received several petitions raising various issues relating to the final rule and special controls.

The concerns raised include the adequacy of the risk assessment method used by the FDA in classifying dental amalgam, the bioaccumulative effect of mercury, the exposure of pediatric populations to mercury vapor, and the adequacy of the clinical studies on dental amalgam. In addition, a recent report on risk assessments issued by the National Academy of Sciences, titled "Science and Decisions: Advancing Risk Assessment, NAP 2009," proposes new approaches to conducting risk assessments. These may be some of the issues the agency asks the advisory committee to review.

Details about the advisory panel meeting will be published in the Federal Register on June 11, 2010 and is available for advanced viewing today only.

For more information:

- Advanced viewing
- FDA website on dental amalgam

Source
U.S. Food and Drug Administration

Article adapted by Medical News Today from original press release.
Visit our dentistry section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
U.S. Food and Drug Administration. "FDA Advisory Panel To Review Dental Amalgam." Medical News Today. MediLexicon, Intl., 11 Jun. 2010. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/191525.php>

APA
U.S. Food and Drug Administration. (2010, June 11). "FDA Advisory Panel To Review Dental Amalgam." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/191525.php.

Please note: If no author information is provided, the source is cited instead.


Dentistry

Most Popular Articles



Follow Our Dentistry News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Dentistry Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »